D 01 Pill - white capsule/oblong, 16mm
Pill with imprint D 01 is White, Capsule/Oblong and has been identified as Zidovudine 100 mg. It is supplied by Aurobindo Pharma.
Zidovudine is used in the treatment of Occupational Exposure; HIV Infection; Reduction of Perinatal Transmission of HIV; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for D 01
Zidovudine
- Imprint
- D 01
- Strength
- 100 mg
- Color
- White
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- Inactive Ingredients
-
microcrystalline cellulose,
corn starch,
sodium starch glycolate type A potato,
magnesium stearate,
ferrosoferric oxide,
shellac,
titanium dioxide,
sodium lauryl sulfate,
gelatin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65862-0107 | Aurobindo Pharma Limited |
| 68084-0461 (Discontinued) | Amerisource Health Services |
Related images for "D 01"
More about zidovudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
- Zidovudine oral/injection drug information
- Zidovudine (Intravenous) (Advanced Reading)
- Zidovudine (Oral) (Advanced Reading)
- Zidovudine Capsules and Tablets
- Zidovudine Syrup
Other brands
Professional resources
- Zidovudine monograph
- Zidovudine (FDA)
- Zidovudine Oral Solution (FDA)
- Zidovudine Syrup (FDA)
- Zidovudine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
